WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MAY ISSUE PUBLISHED
  • May Issue has been successfully launched on 1 May 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

EVALUATION OF ANTIHYPERLIPIDEMIC ACTIVITY OF AQUEOUS EXTRACT OF BUTEA MONOSPERMA L. IN TRITON WR 1339 TREATED HYPERLIPIDEMIC RATS

P. D. Mahure, A.V. Shrirao*, M. Muqitur Rahman, V. S. Chaudhari, N. I. Kochar, A. V. Chandewar

ABSTRACT

Objective: The present work was undertaken to investigate the possible antihyperlipidemic and antioxidant effect of aqueous extract of Butea monosperma L. (BM) flowers on hyperlipidemic rats. Method: Hyperlipidemia was induced in rats by a single intraperitonial (i.p.) injection of Triton WR 1339 (400 mg/kg) and it showed sustained elevated levels of serum cholesterol and triglyceride. The Aqueous extract of Butea monosperma L. flowers (AQ-BM) (200,400 and 600 mg/kg/day) was administered to normal and hyperlipidemic rats for 14 days. Result: Serum and liver tissue were analyzed for lipid profile and antioxidants enzymes and the activity was compared to the cholesterol-lowering drug, Atorvastatin (10 mg/kg). Parameters were altered during hyperlipidemia and reverted back to near normal values after AQ-BM treatment or standard drug Atorvastatin. Lipid peroxidation decreased whereas the activities of superoxide dismutase, glutathione peroxidase and catalase increased in AQ-BM treated rats. Pronounced changes were observed at 600 mg/kg of AQ-BM for 2 weeks and it was comparable to the standard drug Atorvastatin. Conclusion: The current study provides strong evidence that AQ-BM has a remarkable beneficial effect in treating hyperlipidemia and ROS without any side effects at 600 mg/kg/day for 14 days.

Keywords: Butea monosperma L., Hyperlipidemia, Lipid profile, Antioxidant enzyme.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More